triethylenephosphoramide has been researched along with triethylenemelamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frohberg, H; Schencking, MS | 1 |
| SCHMIDT, KH | 1 |
| NADKARNI, MV; SMITH, PK; TRAMS, EG | 1 |
3 other study(ies) available for triethylenephosphoramide and triethylenemelamine
| Article | Year |
|---|---|
Recent findings concerning dose response relationship in mutagenicity testing of chemicals.
Topics: Alkylating Agents; Animals; Antimetabolites; Bone Marrow; Bone Marrow Cells; Chromosomes; Cytogenetics; Dose-Response Relationship, Drug; Humans; Lead; Lethal Dose 50; Lymphocytes; Male; Mercaptopurine; Mesylates; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Mutagens; Mutation; Species Specificity; Time Factors; Triethylenemelamine; Triethylenephosphoramide | 1974 |
[Experimental and comparative results with triethylene melamine, N,N',N"-triethylene phosphoramide and 6-mercaptopurine].
Topics: Animals; Leukemia; Leukemia, Experimental; Mercaptopurine; Mitosis; Neoplasms, Experimental; Phosphoramides; Poisons; Purines; Triethylenemelamine; Triethylenephosphoramide | 1954 |
Preliminary studies on the distribution and fate of TEM, TEPA, and myleran in the human.
Topics: Antineoplastic Agents; Busulfan; Triethylenemelamine; Triethylenephosphoramide | 1959 |